Reduction of plasma autoantibodies against GPIb/IX is associated with increased yield of CD41+PI+ cells
. | Before absorption . | . | . | |
---|---|---|---|---|
. | Process 1* . | Process 2† . | After absorption . | |
Acute ITP no. 1; Plt, 2 × 103/μL | ||||
IgM titer | >160 | >160 | 80 | |
CD41+PI+, % of control | 25 | 25 | 50 | |
Acute ITP no. 2; Plt, 18 × 103/μL | ||||
IgM titer | >20 | >20 | Undetectable | |
CD41+PI+, % of control | 82 | 66 | 120 | |
Healthy control no. 1; Plt, control | ||||
IgM titer | Undetectable | Undetectable | Undetectable | |
CD41+PI+, % of control | 100 | 94 | 100 | |
Healthy control no. 2; Plt, control | ||||
IgM titer | Undetectable | Undetectable | Undetectable | |
CD41+PI+, % of control | 100 | 108 | 100 |
. | Before absorption . | . | . | |
---|---|---|---|---|
. | Process 1* . | Process 2† . | After absorption . | |
Acute ITP no. 1; Plt, 2 × 103/μL | ||||
IgM titer | >160 | >160 | 80 | |
CD41+PI+, % of control | 25 | 25 | 50 | |
Acute ITP no. 2; Plt, 18 × 103/μL | ||||
IgM titer | >20 | >20 | Undetectable | |
CD41+PI+, % of control | 82 | 66 | 120 | |
Healthy control no. 1; Plt, control | ||||
IgM titer | Undetectable | Undetectable | Undetectable | |
CD41+PI+, % of control | 100 | 94 | 100 | |
Healthy control no. 2; Plt, control | ||||
IgM titer | Undetectable | Undetectable | Undetectable | |
CD41+PI+, % of control | 100 | 108 | 100 |